Related Experiment Video

Updated: Aug 21, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

Can SSRIs reduce the risk of preeclampsia in pregnant, depressed patients?

Shandara Durkee Dawes1

  • 1Department of Psychiatry, Los Angeles Neuropsychiatric Institute, University of California, 760 Westwood Plaza, Room C8-846, Los Angeles, CA 90024, USA. sdawes@mednet.ucla.edu

Medical Hypotheses
|November 10, 2004
PubMed

Insights

Preeclampsia shares similarities with coronary artery disease due to endothelial damage. Selective serotonin reuptake inhibitors (SSRIs) may offer benefits for both conditions, including during pregnancy.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Medicine
  • Psychiatry

Background:

  • Preeclampsia is a significant cause of maternal morbidity and mortality.
  • Preeclampsia pathophysiology involves endothelial damage and platelet activation, similar to coronary artery disease.
  • Depression is an independent risk factor for cardiovascular disease and may also be a risk factor for preeclampsia.

Purpose of the Study:

  • To explore the potential role of selective serotonin reuptuptake inhibitors (SSRIs) in managing preeclampsia risk factors.
  • To investigate the overlap in pathophysiology between preeclampsia and coronary artery disease.
  • To examine the potential benefits of SSRIs in pregnant individuals with depression.

Main Methods:

  • This study is a conceptual review and synthesis of existing research.
  • It draws parallels between the pathophysiology of preeclampsia and coronary artery disease.
  • It reviews evidence on the effects of SSRIs on cardiovascular disease and depression.

Main Results:

  • Preeclampsia and coronary artery disease share similar underlying mechanisms involving endothelial dysfunction.
  • Depression is a known risk factor for cardiovascular disease progression.
  • SSRIs have demonstrated efficacy in reducing cardiovascular disease progression, independent of mood improvement.

Conclusions:

  • SSRIs may represent a therapeutic avenue for reducing preeclampsia risk factors, beyond their antidepressant effects.
  • Further research is warranted to investigate the efficacy and safety of SSRIs in preventing or managing preeclampsia.
  • The shared pathophysiology suggests potential for novel therapeutic strategies targeting both cardiovascular health and pregnancy complications.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...